RXO, Inc. has disclosed a notable ownership stake by Orbis Investment Management Limited, which now holds 13.8% of the company's common stock. This significant investment reflects growing confidence in RXO's business model and potential for future growth within the transportation services industry.
RXO, Inc., classified under the SIC code 4700 for Transportation Services, operates primarily in the logistics and transportation sector. The company, which trades on the NYSE under the ticker RXO, has been actively involved in enhancing its operational strategies to better position itself in a competitive market. Recent filings indicate RXO's commitment to transparency and regulatory compliance, as evidenced by its ongoing disclosures.
The recent Schedule 13G/A filing, dated November 6, 2026, reveals that Orbis Investment Management Limited beneficially owns 22,773,348 shares of RXO, representing 13.8% of the company's total shares. This marks the ninth amendment to their ownership report, indicating a sustained interest in RXO. The filing also confirms that Orbis has sole voting and dispositive power over these shares, allowing them significant influence over company decisions.
This development may impact various stakeholders, including RXO's management, employees, and other investors. With Orbis's substantial stake, the company may experience shifts in governance dynamics, potentially leading to strategic changes or new initiatives aimed at enhancing shareholder value.
Looking ahead, the filing does not specify the next steps for RXO or Orbis Investment Management. However, the increased ownership by Orbis may prompt further disclosures or strategic moves in the near future as both entities navigate the evolving landscape of the transportation services industry.
Read Next
Love Scott A reports stock transactions at WesBanco Inc.
Wenger E Philip acquires additional shares of Fulton Financial
Northern Lights Fund Trust III Files Proxy Voting Report
British American Tobacco reports major holdings change
Kirk E. Kleiser Acquires Additional Shares in Catalyst Bancorp
CTT Pharmaceutical CEO Acquires 9,000 Shares of Stock










